Literature DB >> 256545

Congenital malformations: the possible role of diabetes care outside pregnancy.

J Pedersen, L M Mølsted-Pedersen.   

Abstract

A consecutive and prospective series comprising 949 newborn infants of diabetic mothers treated during pregnancy and delivery in the period 1966--1977 has been analysed. The malformation rate was 8.2%. As compared to infants of mothers (White classes B-F alone) controlled outside pregnancy elsewhere, the rate of malformations was significantly reduced (from 14.1 to 7.4%) in fants whose mothers attended two hospitals specializing in the treatment and ambulatory control of diabetics. For diabetics not controlled at a diabetic centre outside pregnancy the malformation rate was 9% in classes B + C and 19.4% in classes D + F, compared to 6.2 and 8.5%, respectively, for those who were controlled. The rates of malformation (total as well as severe alone) were significantly reduced in infants of White's classes D + F, and insignificantly reduced in classes B + C (in class A no comparison could be made). The findings indicate that poor diabetic control outside pregnancy is teratogenic, although the 'disastrous malformation factor' of diabetes appears not to be totally dependent on the degree of compensation of the disbetic metabolism, as measured by the variables usually applied.

Entities:  

Mesh:

Year:  1978        PMID: 256545     DOI: 10.1002/9780470720462.ch13

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  3 in total

Review 1.  Protecting the terminus: t-loops and telomere end-binding proteins.

Authors:  C Wei; M Price
Journal:  Cell Mol Life Sci       Date:  2003-11       Impact factor: 9.261

2.  Diabetic embryopathy: a developmental perspective from fertilization to adulthood.

Authors:  M Castori
Journal:  Mol Syndromol       Date:  2013-02

Review 3.  Congenital heart disease in pregnancies complicated by maternal diabetes mellitus. An international clinical collaboration, literature review, and meta-analysis.

Authors:  Lukas A Lisowski; Paul M Verheijen; Joshua A Copel; Charles S Kleinman; Sander Wassink; Gerard H A Visser; Erik-Jan Meijboom
Journal:  Herz       Date:  2010-02-09       Impact factor: 1.443

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.